Longitudinal assessment of state health agency billing practices
The Association of State and Territorial Health Officials (ASTHO) conducted an online survey of all US state and territorial health agencies in 2014 to document emerging issues in the management, resources, and activities of S/THAs, including the impact of the implementation of the ACA. The survey will be re-administered in February 2015.
In 2014, thirty-seven states, one territory, and one freely-associated state responded to the survey. While S/THAs vary in the payers billed by type of service, respondents reported that they did not bill third-party payers for the majority of ten specific services surveyed on. However, 59 percent of respondents indicated that they are engaged in efforts to increase billing for clinical services, and nearly half of respondents indicated that they are working to increase billing. The results will be updated with longitudinal comparisons between the 2014 and 2015 data.
Though the implementation of the ACA has not yet demonstrated an impact on the billing practices of S/THAs in the areas studied, there may be future implications, including expanded billing of private insurers and changes in the types of services that S/THAs bill for.
Learning Areas:Administration, management, leadership
Public health administration or related administration
Public health or related research
Compare the billing practices for state and territorial health agencies in 2014 to the practices in 2015. Describe the changes in services for which state and territorial health agencies bill for in 2014 and 2015.
Keyword(s): Public Health Administration, Public Health Research
Qualified on the content I am responsible for because: I have supported several funded projects on public health systems and services research, including projects on state and territorial health department resources, finance, and management.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.